VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical ...

The company’s non-steroidal immunomodulator met the primary endpoint in a Phase II trial as a treatment for post-op ...

Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery. The results support a regulatory ...

SpyGlass prepares for End of Phase II meeting with the FDA to advance its Drug Delivery Platform into Phase III pivotal studiesInnovative ...

Light therapy (phototherapy) for many types of depression may have fewer and milder side effects and work more quickly than traditional depression treatments. Talk with a doctor before use.

Therapy may be a successful strategy to help you cope with stress. Types of therapies for stress and other conditions include cognitive behavioral therapy, exposure therapy, psychodynamic therapy ...

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

EO2002 demonstrated significant improvements in BCVA and corneal health, with a strong safety profile and no serious adverse events reported. The therapy's Magnetic Cell Delivery technology enables ...

Heat therapy, also known as thermotherapy, is a common treatment modality for easing pain, reducing muscle stiffness, and promoting circulation to enhance the healing process. It involves the ...